| 1 | Rasopathy | Enrichment | HRAS, KRAS, MAP2K1, MAP2K2, NRAS, SOS1, SOS2 | 16.00 |
| 2 | Noonan syndrome 1 | Enrichment | HRAS, KRAS, MAP2K1, MAP2K2, NRAS, SOS1, SOS2 | 10.95 |
| 3 | Noonan syndrome and noonan-related syndrome | Enrichment | HRAS, KRAS, MAP2K1, MAP2K2, NRAS, SOS1 | 10.54 |
| 4 | Lung non-small cell carcinoma | Enrichment | HRAS, KRAS, MAP2K1, NRAS | 7.87 |
| 5 | Schimmelpenning-feuerstein-mims syndrome | Enrichment | HRAS, KRAS, NRAS | 7.16 |
| 6 | Cardiofaciocutaneous syndrome 1 | Enrichment | KRAS, MAP2K1, MAP2K2 | 7.16 |
| 7 | Cardiofaciocutaneous syndrome | Enrichment | KRAS, MAP2K1, MAP2K2 | 7.16 |
| 8 | Nevus, epidermal | Enrichment | HRAS, KRAS, NRAS | 6.22 |
| 9 | Noonan syndrome 3 | Enrichment | HRAS, KRAS, SOS1 | 6.22 |
| 10 | Loeys-dietz syndrome | Enrichment | SMAD2, SMAD3, TGFB3 | 5.85 |
| 11 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | SMAD2, SMAD3, SMAD4, TGFB3 | 5.28 |
| 12 | Ras-associated autoimmune leukoproliferative disorder | Enrichment | KRAS, NRAS | 5.16 |
| 13 | Langerhans cell histiocytosis | Enrichment | MAP2K1, NRAS | 4.69 |
| 14 | Large congenital melanocytic nevus | Enrichment | HRAS, NRAS | 4.69 |
| 15 | Chronic myelogenous leukemia, bcr-abl1 positive | Enrichment | KRAS, NRAS | 4.39 |
| 16 | Dilated cardiomyopathy | Enrichment | EMD, KIF5B, TAFAZZIN, TMEM43 | 4.24 |
| 17 | Differentiated thyroid carcinoma | Enrichment | HRAS, KRAS, NRAS | 4.22 |
| 18 | Emery-dreifuss muscular dystrophy 2, autosomal dominant | Enrichment | SYNE2, TMEM43 | 3.99 |
| 19 | Thyroid cancer, nonmedullary, 2 | Enrichment | HRAS, NRAS | 3.85 |
| 20 | Capillary malformation-arteriovenous malformation 1 | Enrichment | KRAS, MAP2K1 | 3.85 |
| 21 | Leukemia, chronic myeloid | Enrichment | KRAS, NRAS | 3.85 |
| 22 | Gallbladder cancer | Enrichment | KRAS, SMAD4 | 3.85 |
| 23 | Follicular thyroid carcinoma | Enrichment | HRAS, NRAS | 3.85 |
| 24 | Melanocytic nevus syndrome, congenital | Enrichment | HRAS, NRAS | 3.72 |
| 25 | Arteriovenous malformation | Enrichment | HRAS, MAP2K1 | 3.61 |
| 26 | Myopathy, x-linked, with excessive autophagy | Enrichment | HRAS, MAP2K1 | 3.52 |
| 27 | Juvenile myelomonocytic leukemia | Enrichment | KRAS, NRAS | 3.35 |
| 28 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | TGFB3, TMEM43 | 3.35 |
| 29 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | TGFB3, TMEM43 | 3.35 |
| 30 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | TGFB3, TMEM43 | 3.21 |
| 31 | Arteriovenous malformations of the brain | Enrichment | KRAS, LEMD3 | 2.94 |
| 32 | Pancreatic cancer | Enrichment | KRAS, SMAD4 | 2.70 |
| 33 | Buschke-ollendorff syndrome | Enrichment | LEMD3 | 2.58 |
| 34 | Oculoectodermal syndrome | Enrichment | KRAS | 2.58 |
| 35 | Noonan syndrome 4 | Enrichment | SOS1 | 2.58 |
| 36 | Arrhythmogenic right ventricular dysplasia, familial, 5 | Enrichment | TMEM43 | 2.58 |
| 37 | Melorheostosis, isolated | Enrichment | MAP2K1 | 2.58 |
| 38 | Cardiofaciocutaneous syndrome 3 | Enrichment | MAP2K1 | 2.58 |
| 39 | Melanosis, neurocutaneous | Enrichment | NRAS | 2.58 |
| 40 | Noonan syndrome 9 | Enrichment | SOS2 | 2.58 |
| 41 | Dyskinesia with orofacial involvement, autosomal dominant | Enrichment | ADCY5 | 2.58 |
| 42 | Noonan syndrome 6 | Enrichment | NRAS | 2.58 |
| 43 | Greenberg dysplasia | Enrichment | LBR | 2.58 |
| 44 | Pelger-huet anomaly | Enrichment | LBR | 2.58 |
| 45 | Noonan syndrome 13 | Enrichment | MAPK1 | 2.58 |
| 46 | Rhizomelic skeletal dysplasia with or without pelger-huet anomaly | Enrichment | LBR | 2.58 |
| 47 | Neurodevelopmental disorder with hyperkinetic movements and dyskinesia | Enrichment | ADCY5 | 2.58 |
| 48 | Cardiofaciocutaneous syndrome 2 | Enrichment | KRAS | 2.58 |
| 49 | Dyskinesia with orofacial involvement, autosomal recessive | Enrichment | ADCY5 | 2.58 |
| 50 | Melorheostosis | Enrichment | MAP2K1 | 2.58 |
| 51 | Emery-dreifuss muscular dystrophy 7, autosomal dominant | Enrichment | TMEM43 | 2.58 |
| 52 | Emery-dreifuss muscular dystrophy 5, autosomal dominant | Enrichment | SYNE2 | 2.58 |
| 53 | Deafness, autosomal recessive 76 | Enrichment | SYNE4 | 2.58 |
| 54 | Cardiofaciocutaneous syndrome 4 | Enrichment | MAP2K2 | 2.58 |
| 55 | Nestor-guillermo progeria syndrome | Enrichment | BANF1 | 2.58 |
| 56 | Loeys-dietz syndrome 6 | Enrichment | SMAD2 | 2.58 |
| 57 | Reynolds syndrome | Enrichment | LBR | 2.58 |
| 58 | Loeys-dietz syndrome 5 | Enrichment | TGFB3 | 2.58 |
| 59 | Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies | Enrichment | RHOA | 2.58 |
| 60 | Auditory neuropathy, autosomal dominant 3 | Enrichment | TMEM43 | 2.58 |
| 61 | Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies | Enrichment | RHOA | 2.58 |
| 62 | Melorheostosis with osteopoikilosis | Enrichment | LEMD3 | 2.58 |
| 63 | Congenital heart defects, multiple types, 8, with or without heterotaxy | Enrichment | SMAD2 | 2.58 |
| 64 | Heritable thoracic aortic disease | Enrichment | SMAD4 | 2.58 |
| 65 | Congenital pulmonary airway malformation | Enrichment | KRAS | 2.58 |
| 66 | Idiopathic hypercalciuria | Enrichment | ADCY10 | 2.58 |
| 67 | Qualitative or quantitative defects of plectin | Enrichment | PLEC | 2.58 |
| 68 | Isolated osteopoikilosis | Enrichment | LEMD3 | 2.58 |
| 69 | Phakomatosis pigmentokeratotica | Enrichment | HRAS | 2.58 |
| 70 | Neurocutaneous melanocytosis | Enrichment | NRAS | 2.58 |
| 71 | Bladder cancer | Enrichment | HRAS, KRAS | 2.58 |
| 72 | Non-immune hydrops fetalis | Enrichment | HRAS, KRAS | 2.52 |
| 73 | Leukemia, acute myeloid | Enrichment | KRAS, NRAS | 2.30 |
| 74 | Myopathy | Enrichment | EMD, PLEC | 2.30 |
| 75 | Epidermolysis bullosa simplex 5a, ogna type | Enrichment | PLEC | 2.28 |
| 76 | Fibromatosis, gingival, 1 | Enrichment | SOS1 | 2.28 |
| 77 | Hypercalciuria, absorptive, 2 | Enrichment | ADCY10 | 2.28 |
| 78 | Myhre syndrome | Enrichment | SMAD4 | 2.28 |
| 79 | Costello syndrome | Enrichment | HRAS | 2.28 |
| 80 | Epidermolysis bullosa simplex 5b, with muscular dystrophy | Enrichment | PLEC | 2.28 |
| 81 | Kyphomelic dysplasia | Enrichment | CCN2 | 2.28 |
| 82 | Grange syndrome | Enrichment | YY1AP1 | 2.28 |
| 83 | Myopathy, x-linked, with postural muscle atrophy | Enrichment | EMD | 2.28 |
| 84 | Pulmonic stenosis | Enrichment | SOS1 | 2.28 |
| 85 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | Enrichment | SMAD4 | 2.28 |
| 86 | Encephalocraniocutaneous lipomatosis | Enrichment | KRAS | 2.28 |
| 87 | Muscular dystrophy, limb-girdle, autosomal recessive 17 | Enrichment | PLEC | 2.28 |
| 88 | Loeys-dietz syndrome 3 | Enrichment | SMAD3 | 2.28 |
| 89 | Spondyloepimetaphyseal dysplasia, li-shao-li type | Enrichment | CCN2 | 2.28 |
| 90 | Autosomal recessive limb-girdle muscular dystrophy type 2q | Enrichment | PLEC | 2.28 |
| 91 | Osteopoikilosis | Enrichment | LEMD3 | 2.28 |
| 92 | Loeys-dietz syndrome 4 | Enrichment | TGFB3 | 2.28 |
| 93 | 12q14 microdeletion syndrome | Enrichment | LEMD3 | 2.28 |
| 94 | Skeletal muscle disease | Enrichment | KIF5B | 2.28 |
| 95 | Tafro syndrome | Enrichment | MAP2K2 | 2.28 |
| 96 | X-linked emery-dreifuss muscular dystrophy | Enrichment | EMD | 2.28 |
| 97 | Wooly hair nevus | Enrichment | HRAS | 2.28 |
| 98 | Gastric cancer | Enrichment | KRAS, SMAD4 | 2.24 |
| 99 | Hypertrophic cardiomyopathy | Enrichment | KIF5B, TMEM43 | 2.24 |
| 100 | Juvenile polyposis syndrome | Enrichment | SMAD4 | 2.10 |
| 101 | Nuchal bleb, familial | Enrichment | SOS1 | 2.10 |
| 102 | Barth syndrome | Enrichment | TAFAZZIN | 2.10 |
| 103 | Loeys-dietz syndrome 1 | Enrichment | SMAD2 | 2.10 |
| 104 | Epidermolysis bullosa simplex 5d, generalized intermediate, autosomal recessive | Enrichment | PLEC | 2.10 |
| 105 | Spermatocytoma | Enrichment | HRAS | 2.10 |
| 106 | Familial isolated dilated cardiomyopathy | Enrichment | TAFAZZIN, TMPO | 2.06 |
| 107 | Chorea, benign hereditary | Enrichment | ADCY5 | 1.98 |
| 108 | Diffuse gastric and lobular breast cancer syndrome | Enrichment | KRAS | 1.98 |
| 109 | Emery-dreifuss muscular dystrophy 1, x-linked | Enrichment | EMD | 1.98 |
| 110 | Neurofibromatosis-noonan syndrome | Enrichment | MAP2K2 | 1.98 |
| 111 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | MAPK1 | 1.98 |
| 112 | Epidermolysis bullosa simplex 5c, with pyloric atresia | Enrichment | PLEC | 1.98 |
| 113 | Emery-dreifuss muscular dystrophy | Enrichment | EMD | 1.98 |
| 114 | Lung sarcomatoid carcinoma | Enrichment | KRAS | 1.98 |
| 115 | Aortic aneurysm | Enrichment | SMAD3 | 1.98 |
| 116 | Pilocytic astrocytoma | Enrichment | KRAS | 1.98 |
| 117 | Epidermolytic nevus | Enrichment | HRAS | 1.98 |
| 118 | Gingival fibromatosis | Enrichment | SOS1 | 1.98 |
| 119 | Male infertility due to gonadal dysgenesis or sperm disorder | Enrichment | SOS2 | 1.98 |
| 120 | Epidermolysis bullosa simplex 2f, with mottled pigmentation | Enrichment | PLEC | 1.88 |
| 121 | Epidermolysis bullosa simplex 1a, generalized severe | Enrichment | PLEC | 1.88 |
| 122 | Arrhythmogenic right ventricular dysplasia, familial, 1 | Enrichment | TGFB3 | 1.88 |
| 123 | Kearns-sayre syndrome | Enrichment | KIF5B | 1.88 |
| 124 | Arrhythmogenic right ventricular dysplasia 1 | Enrichment | TGFB3 | 1.88 |
| 125 | Aplasia cutis congenita | Enrichment | PLEC | 1.88 |
| 126 | Diffuse cutaneous systemic sclerosis | Enrichment | CCN2 | 1.88 |
| 127 | Generalized juvenile polyposis/juvenile polyposis coli | Enrichment | SMAD4 | 1.88 |
| 128 | Hemihyperplasia, isolated | Enrichment | RHOA | 1.80 |
| 129 | Epidermolysis bullosa, junctional 5b, with pyloric atresia | Enrichment | PLEC | 1.80 |
| 130 | Limited scleroderma | Enrichment | CCN2 | 1.80 |
| 131 | Breast adenocarcinoma | Enrichment | KRAS | 1.80 |
| 132 | Lung squamous cell carcinoma | Enrichment | KRAS | 1.80 |
| 133 | Hereditary hemorrhagic telangiectasia | Enrichment | SMAD4 | 1.73 |
| 134 | Pilomyxoid astrocytoma | Enrichment | KRAS | 1.73 |
| 135 | Epidermolysis bullosa simplex | Enrichment | PLEC | 1.73 |
| 136 | Colorectal cancer | Enrichment | NRAS, SMAD4 | 1.65 |
| 137 | Familial isolated arrhythmogenic right ventricular dysplasia | Enrichment | TMEM43 | 1.63 |
| 138 | Familial thoracic aortic aneurysm and dissection | Enrichment | SMAD3 | 1.63 |
| 139 | Specific learning disability | Enrichment | MAPK1 | 1.54 |
| 140 | Lip and oral cavity carcinoma | Enrichment | HRAS | 1.50 |
| 141 | Aortic valve disease 1 | Enrichment | SOS1 | 1.47 |
| 142 | Protein-deficiency anemia | Enrichment | NRAS | 1.47 |
| 143 | Multiple sclerosis | Enrichment | PLEC | 1.44 |
| 144 | Aortic aneurysm, familial thoracic 1 | Enrichment | SMAD3 | 1.44 |
| 145 | Lung cancer susceptibility 3 | Enrichment | KRAS | 1.44 |
| 146 | 46,xy partial gonadal dysgenesis | Enrichment | SOS1 | 1.44 |
| 147 | Lynch syndrome | Enrichment | KRAS | 1.41 |
| 148 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | TMEM43 | 1.38 |
| 149 | Rhabdomyosarcoma | Enrichment | HRAS | 1.38 |
| 150 | Heart, malformation of | Enrichment | MAPK1 | 1.33 |
| 151 | Neuromuscular disease | Enrichment | EMD | 1.33 |
| 152 | Neuropathy, hereditary motor and sensory, okinawa type | Enrichment | EMD | 1.31 |
| 153 | Ehlers-danlos syndrome | Enrichment | SMAD3 | 1.31 |
| 154 | Attention deficit-hyperactivity disorder | Enrichment | KIF5B | 1.25 |
| 155 | Skin disease | Enrichment | PLEC | 1.25 |
| 156 | Jeune thoracic dystrophy | Enrichment | LBR | 1.19 |
| 157 | Hydrops fetalis, nonimmune | Enrichment | HRAS | 1.18 |
| 158 | Asphyxiating thoracic dystrophy | Enrichment | LBR | 1.14 |
| 159 | Lung cancer | Enrichment | KRAS | 1.09 |
| 160 | Connective tissue disease | Enrichment | SMAD3 | 1.09 |
| 161 | Short-rib thoracic dysplasia 1 with or without polydactyly | Enrichment | LBR | 1.08 |
| 162 | Left ventricular noncompaction | Enrichment | TAFAZZIN | 1.05 |
| 163 | Non-syndromic genetic deafness | Enrichment | SYNE4 | 1.04 |
| 164 | Cerebral palsy | Enrichment | SYNE2 | 1.01 |
| 165 | Nonsyndromic hearing loss | Enrichment | SYNE4 | 0.98 |
| 166 | Hereditary breast carcinoma | Enrichment | KRAS | 0.96 |
| 167 | Thrombocytopenia | Enrichment | SMAD4 | 0.92 |
| 168 | Spastic ataxia | Enrichment | SYNE2 | 0.88 |
| 169 | Hereditary breast ovarian cancer syndrome | Enrichment | KRAS | 0.87 |
| 170 | Myeloma, multiple | Enrichment | KRAS | 0.86 |
| 171 | Breast cancer | Enrichment | KRAS | 0.74 |
| 172 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | SYNE4 | 0.68 |
| 173 | Ovarian cancer | Enrichment | KRAS | 0.63 |
| 174 | Autism spectrum disorder | Enrichment | MAP2K1 | 0.60 |
| 175 | Microcephaly | Enrichment | MAPK1 | 0.55 |
| 176 | Inherited cancer-predisposing syndrome | Enrichment | SMAD4 | 0.53 |